QR Kod

Rivaroxaban Plus Aspirin for Extended Thromboprophylaxis in Acutely Ill Medical Patients: Insights from the MARINER Trial

Background The MARINER trial evaluated whether postdischarge thromboprophylaxis with rivaroxaban could reduce the primary outcome of symptomatic venous thromboembolism (VTE) or VTE-related death in acutely ill medical patients at risk for VTE. Although aspirin use was not randomized, approximately h...

Ful tanımlama

Kaydedildi:
Asıl Yazarlar: Alex C. Spyropoulos, Mark Goldin, Walter Ageno, Gregory W. Albers, C. Gregory Elliott, William R. Hiatt, Jonathan L. Halperin, Gregory Maynard, P. Gabriel Steg, Jeffrey I. Weitz, Theodore E. Spiro, Wentao Lu, Jessica Marsigliano, Gary E. Raskob, Elliot S. Barnathan
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Georg Thieme Verlag KG 2022-07-01
Seri Bilgileri:TH Open
Konular:
aspirin
combined modality therapy
hospitalization
rivaroxaban
venous thromboembolism
Online Erişim:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0042-1750379
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller